Benitec Biopharma Limited P/S ratio

P/S ratio of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/S ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its sales per share. It is used by investors mainly because it’s less volatile than P/E and less subject to accounting manipulation. A low P/S ratio compare to historical average or other companies in the same industry might indicate undervaluation.

Highlights and Quick Summary

Current P/S ratio of Benitec Biopharma Limited is 126.39 (as of June 30, 2022)
  • P/S ratio for the quarter ending December 31, 2022 was 57.02 (a -54.88% decrease compared to previous quarter)
  • Year-over-year quarterly P/S ratio decreased by -92.28%
  • Annual P/S ratio for 2022 was 126.39 (a -83.63% decrease from previous year)
  • Annual P/S ratio for 2022 was 772.11 (a 149.56% increase from previous year)
  • Annual P/S ratio for 2021 was 309.39 (a 3.4% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/S ratio of Benitec Biopharma Limited

Most recent P/S ratioof BNTC including historical data for past 10 years.

Interactive Chart of P/S ratio of Benitec Biopharma Limited

Benitec Biopharma Limited P/S ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – 57.02 126.39 251.6 126.39
2021 – 738.3 309.39 1168.69 309.39
2020 268.75 56.11 0.4 0.04 0.4
2019 – – 1.26 0.0 0.0
2018 – – – – 0.0
2017 – – – 0.0 0.0
2016 – – – 0.0 0.0
2015 – – – – 0.0
2014 – – – – 0.0
2013 – – – – 0.0

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology
© stockrow.com